Strategic Overview of Global Preventable Vaccine Market 2012-2016

1
Strategic Overview of Global Preventable Vaccine
Market 2012-2016
Bharat Book Bureau
2
Summary

• TechNavio's analysts forecast the Strategic
  Overview of Global Preventable Vaccine Market to
  grow at a CAGR of 8.99 percent over the period
  2012-2016. One of the key factors contributing to
  this market growth is the increase in demand for
  vaccination. The Strategic Overview of Global
  Preventable Vaccine market has also been
  witnessing the trend of increase in market
  consolidation. However, the emergence of regional
  players could pose a challenge to the growth of
  this market.

3
Continue

• The Strategic Overview of Global Preventable
  Vaccine Market 2012-2016, has been prepared based
  on an in-depth market analysis with inputs from
  industry experts. The report covers Americas, and
  the EMEA and APAC regions it also covers the
  Strategic Overview of Global Preventable Vaccine
  Market landscape and its growth prospects in the
  coming years. The report also includes a
  discussion of the key vendors operating in this
  market.Key vendors dominating this space
  include GlaxoSmithKline plc. Sanofi Pasteur SA,
  Merck and Co. Inc., Novartis AG, Pfizer Inc.,
  Emergent BioSolutions Inc .

4
Continue

• Key questions answered in this reportWhat
  will the market size be in 2016 and at what will
  be the growth rate?What are key market
  trends?What is driving this market?What are the
  challenges to market growth?Who are the key
  vendors in this market space?What are the market
  opportunities and threats faced by key
  vendors?What are the strengths and weaknesses of
  each of these key vendors?

5
Table of Contents

• 01. Executive Summary02. List of
  Abbreviations03. Introduction04. Market
  Research MethodologyMarket Research
  ProcessResearch DesignResearch Methodology05.
  Scope of the ReportMarket OverviewProduct
  Offerings06. Vaccine06.1 Introduction06.2
  Types of VaccinesLive Attenuated (weakened)
  VaccineKilled (inactivated) VaccineToxoid
  VaccineGenetically Modified/Engineered Vaccine

6
Continue..

• 06.3 Subunit Vaccines06.4 Conjugate
  Vaccines06.5 DNA Vaccines06.6 Recombinant
  Vector Vaccines06.7 Vaccine Approval Process07.
  Global Preventable Vaccines Market07.1 Market
  Size and Forecast07.2 Global Preventable Vaccine
  Market Segmentation07.3 Global Preventable
  Vaccine Market Share by Vaccine Type 201207.4
  Global Preventable Vaccine Market by Revenue
  2012-2016(US billions)08. Competitive Landscape
  of Global Preventable Vaccine Market08.1 Global
  Preventable Vaccine Market Share by Vendor
  201208.2 Global Preventable Vaccine Market Share
  by Vaccine Type 201608.3 Global Preventable
  Vaccine Market Share by Vaccine Type 2012-2016

7
For More Information Kindly Visit On

• http//www.bharatbook.com/market-research-rep
  orts/healthcare-market-research-report/strategic-o
  verview-of-global-preventable-vaccine-market-2012-
  2016.html
• Or visit us at

• Bharat Book Burea Phone [phone],
  27810773Toll Free No for USA/Canada
  1-866-279-8368
• E-mail info_at_bharatbook.com
• Website www.bharatbook.com
• Twitter https//twitter.com/BharatBook
• Blog http//www.bharatbook.com/market-reports-blo
  g/